/Companies

Oxford Biodynamics

Oxford, GB · Incorporated in United Kingdom · 2 known investors

Find your way into Oxford Biodynamics

Sign up to find every way you can get introduced to Oxford Biodynamics

  • Your email: who you already know at Oxford Biodynamics, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Oxford Biodynamics team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Oxford BioDynamics develops precision clinical diagnostic blood tests for detecting cancer and predicting treatment response in cancer patients, using its proprietary 3D genomic biomarker platform. The company serves oncologists and patients in the United States and internationally through its commercially available tests and partnerships with major pharmaceutical companies and research institutions.

Founders & leadership

AAAlexandre Akoulitchev
Alexandre AkoulitchevFounder
JB
Jon BurrowsChief Executive Officer
PSPaul Stockdale
Paul StockdaleChief Financial Officer

Board

SDStephen Diggle
Stephen DiggleBoard directorAdvisor at Vulpes Ventures
DH
David HolbrookBoard director
MW
Matthew WakefieldBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$5M disclosed across 1 round · 2021

▶$5MraisedNov 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexandre AkoulitchevDirector
  • David HolbrookDirector
  • Stephen DiggleDirector
  • Jon BurrowsExecutive Officer, Director
  • Paul StockdaleExecutive Officer, Director
  • Matthew WakefieldDirector
Offering amount
$5M
Amount sold
$5M
First sale
Oct 2021
Incorporated
Other, United Kingdom
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Oxford Biodynamics do?
Oxford BioDynamics develops precision clinical diagnostic blood tests for detecting cancer and predicting treatment response in cancer patients, using its proprietary 3D genomic biomarker platform. The company serves oncologists and patients in the United States and internationally through its commercially available tests and partnerships with major pharmaceutical companies and research institutions.
Who founded Oxford Biodynamics?
Oxford Biodynamics was founded by Alexandre Akoulitchev.
Who are Oxford Biodynamics's investors?
Oxford Biodynamics's investors include Seneca Partners, Vulpes Ventures.
How much funding has Oxford Biodynamics raised?
Oxford Biodynamics has disclosed $5M raised across 1 round.
Where is Oxford Biodynamics headquartered?
Oxford Biodynamics is headquartered in Oxford, GB.